Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Takehara

Showing results (1-10 of 547) with videos related to

Pageof 55
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 11, 2022
[Current status and issues of viral hepatitis medical care]Tetsuo Takehara
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Vaniprevir with pegylated interferon and ribavirin in treatment for chronic hepatitis C]Tetsuo Takehara
Expert Review of Anti-Infective Therapy|June 3, 2014
Simeprevir for the treatment of chronic hepatitis C genotype 1 infectionTetsuo Takehara
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[The Catting-edge of Medicine; Anti-viral therapies for chronic hepatitis C]Tetsuo Takehara
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 10, 2017
Recent research trends on the pathogenesis of nonalcoholic fatty liver diseaseTetsuo Takehara
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 2, 2010
[Antiviral therapy for chronic hepatitis C: current status and perspectives]Tetsuo Takehara
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 12, 2022
[Looking back on the 63rd Annual Meeting of the Japanese Society of Gastroenterology]Tetsuo Takehara
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Re-treatment for patients with chronic hepatitis C who previously failed to peginterferon/ribavirin therapy]Tetsuo Takehara
Hepatology (Baltimore, Md.)|December 20, 2021
ReplyTakahiro Kodama, Tetsuo Takehara
Journal of Gastroenterology|February 28, 2006
Antiviral therapy for chronic hepatitis C: past, present, and futureNorio Hayashi, Tetsuo Takehara
Pageof 55

Showing results (1-10 of 547) with videos related to

Sort By:
Pageof 55
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 11, 2022
[Current status and issues of viral hepatitis medical care]Tetsuo Takehara
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Vaniprevir with pegylated interferon and ribavirin in treatment for chronic hepatitis C]Tetsuo Takehara
Expert Review of Anti-Infective Therapy|June 3, 2014
Simeprevir for the treatment of chronic hepatitis C genotype 1 infectionTetsuo Takehara
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[The Catting-edge of Medicine; Anti-viral therapies for chronic hepatitis C]Tetsuo Takehara
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 10, 2017
Recent research trends on the pathogenesis of nonalcoholic fatty liver diseaseTetsuo Takehara
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 2, 2010
[Antiviral therapy for chronic hepatitis C: current status and perspectives]Tetsuo Takehara
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 12, 2022
[Looking back on the 63rd Annual Meeting of the Japanese Society of Gastroenterology]Tetsuo Takehara
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Re-treatment for patients with chronic hepatitis C who previously failed to peginterferon/ribavirin therapy]Tetsuo Takehara
Hepatology (Baltimore, Md.)|December 20, 2021
ReplyTakahiro Kodama, Tetsuo Takehara
Journal of Gastroenterology|February 28, 2006
Antiviral therapy for chronic hepatitis C: past, present, and futureNorio Hayashi, Tetsuo Takehara
Pageof 55